reported that radiomics combining contrast-enhanced spectral mammography performed well in predicting histological subtypes of breast cancer, with accuracies of 90.87%and 84.80% in discriminating HER2 + /HER2 − and Ki67 + /Ki67 − breast cancer, respectively. This evidence concerns the gene ERBB2 and breast cancer.